Maha At Elsebaie, MD
Hematology & Oncology Physician · Chicago, IL
Maha At Elsebaie, MD is a hematology & oncology physician with a practice address in Chicago, Illinois, and NPI 1407473242, issued on Jun 27, 2020. Check the license (Illinois 036.164049, as entered in NPPES) on the Illinois Department of Financial and Professional Regulation; the Medicare figures below come from public CMS files.
- Name
- Maha At Elsebaie
- Credential
- MD
- Primary taxonomy
- Hematology & Oncology Physician 207RH0003X
- License number
- 036.164049 IL
Self-reported in NPPES; status is on the state search - Practice location
- 5841 S Maryland Ave # MC2115, Chicago, IL 60637
- Phone
- (773) 702-2731
- Enumerated
- Jun 27, 2020
- Record last updated
- May 23, 2024
- Entity
- Type 1 · individual
8 nearest hematology & oncology physician records → All 666 in Illinois → Look up another NPI →
Also registered at 5841 S Maryland Ave # MC2115
A shared address usually means a shared clinic or building; it does not show who employs whom.
- Christine Bestvina, M.D.Medical Oncology Physician1720354137
- Jamie Brewer, M.D.Hematology & Oncology Physician1508153479
- Meytal Chernoff, M.D.Hematology & Oncology Physician1225881519
- Dawn Conway, AGNP-CPrimary Care Nurse Practitioner1023721156
- Marina Chiara Garassino, MDMedical Oncology Physician1053999599
- Betul Gok Yavuz, MD, PHDHematology & Oncology Physician1861124885
Verify Maha At Elsebaie in five checks
- 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
- 2LicenseActive license and public ordersIllinois Department of Financial and Professional Regulation
Search for license 036.164049Check the board - 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
- 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
- 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
97% fewer Medicare Part D claims than the average hematology & oncology physician in 2024
30 Medicare Part D claims for 17 beneficiaries, against an average of 877 among the 10,784 providers of this specialty who prescribed in Part D. Brand-name drugs were 37% of claims.
Source: CMS Medicare Part D Prescribers by Provider and Drug, 2024 (data.cms.gov). Part D covers prescriptions for Medicare patients only; drugs with fewer than 11 claims are not published.
The practice group's MIPS final score for 2023 (Medicare payment program): 84.6 of 100
The Merit-based Incentive Payment System score is reported for the practice group, not for one clinician alone. Four categories are weighted into the final score; the average among 454,083 clinicians with a measured score was 83.5.
Source: CMS Quality Payment Program, MIPS performance year 2023, group reporting; category weights for 2023 (qpp.cms.gov).
Maha At Elsebaie among 666 hematology & oncology physician records in Illinois
Maha At Elsebaie, MD is one of 666 hematology & oncology physician records with a practice address in Illinois. 84% of them appear in a Medicare file (Part D prescribing, MIPS, Open Payments or Medicare group billing); this one does. Its NPI, issued in 2020, is newer than 92% of them.
- NPI issued2020 · 92% of these records are older, 6% newer
- In a Medicare fileYes · 84% of these records are
- In the CMS Doctors and Clinicians fileNo · 69% of these records are
- Record last updated2024 · 49% of these records were not updated in five years or more
Source: CMS NPPES, file of Aug 9, 2026, every record with primary taxonomy 207RH0003X and a Illinois practice address; Medicare files: CMS Part D Prescribers 2024, MIPS 2023, Open Payments 2024, Doctors and Clinicians (data.cms.gov).
Hematology & Oncology Physician providers in Illinois
There are 666 hematology & oncology physician records in Illinois.
All 666 in Illinois → Every provider in Chicago → Hematology & Oncology Physician nationwide →
The 8 hematology & oncology physician records with the nearest ZIP codes
- Julia Ashenhurst, M.D.Chicago, IL 606371336225358
- Christopher DaughertyChicago, IL 606371063574523
- Gini FlemingChicago, IL 606371407918964
- Thomas GajewskiChicago, IL 606371194888610
- Philip HoffmanChicago, IL 606371700949229
- Richard LarsonChicago, IL 606371114089661
- Rita NandaChicago, IL 606371568524015
- Sunil NarulaChicago, IL 606371861428583
Common questions
What is Maha At Elsebaie, MD's NPI number?
Maha At Elsebaie, MD's National Provider Identifier (NPI) is 1407473242, issued on Jun 27, 2020. An NPI identifies a provider in billing; it is not a license.
Where is Maha At Elsebaie, MD located?
The NPPES record lists a practice address at 5841 S Maryland Ave # MC2115, Chicago, IL, 60637. Phone: (773) 702-2731. Providers update this record themselves, so call before visiting.
How can I verify Maha At Elsebaie, MD's license?
NPPES lists Illinois license number 036.164049, as entered by the provider. Search the Illinois Department of Financial and Professional Regulation at https://idfpr.illinois.gov/checklicense.html. The NPPES record confirms identity only; the state search shows license status, expiration and public orders.
How much does Maha At Elsebaie, MD prescribe under Medicare Part D?
In 2024, Maha At Elsebaie, MD had 30 Medicare Part D claims for 17 beneficiaries; the average among hematology & oncology physician prescribers was 877. Part D covers Medicare prescriptions only.
What is Maha At Elsebaie, MD's MIPS final score?
The 2023 MIPS final score is 84.6 of 100, reported for the practice group. The average among 454,083 clinicians with a measured score was 83.5.
Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. Medicare files from data.cms.gov. An NPI identifies who bills; it is not a license.
Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.